Homepage

Considerations in Prescribing

Imetelstat: A First-in-Class Telomerase Inhibitor for the Treatment of Patients With Lower-Risk Myelodysplastic Syndromes and Anemia

Hetalkumari Patel, PharmD, BCOP, Selamawit Yohannes, MPAS, PA-C, Elissa Brunaugh, MPAS, PA-C Et al.

June 25, 2025

12 min read

Review Article

Care Optimization for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm Receiving Tagraxofusp

Karolina Faysman, MSN, AOCNP®, DNP-C, Joelle Rubin, NP, Amber Lubas, PA-C, Et al.

July 2, 2025

24 min read

Translating Research Into Practice

Primer on Plain Language Summaries for Advanced Practice Providers With Published Examples and Practical Applications to Practice

Kimberly Podsada, MSN, NP-C, Tiffany N. Jones, RN, MSN, ACNP-BC, Joanne C. Ryan, PhD, RN Et al.

June 25, 2025

25 min read

Grand Rounds

Ductal Carcinoma In Situ: Non-Mass Enhancement on MRI 10 Years Before Mammographic Microcalcifications

Nancy W. Stead, MD,Andria P. Caton, RN, OCN, CHPN

In developed countries, the lifetime risk of developing breast cancer among women is 11%. Therefore, screening asymptomatic women for bre...

Volume 16, Number 3 (May/Jun 2025)

16 min read

Grand Rounds

Digging into the Cause of Drug-Induced Thrombocytopenia: A Case Report

Vivian A. Pham, PharmD,Christopher Selby, PharmD, BCOP

Volume 16, Number 2 (Mar/Apr 2025)

17 min read

Practice Matters

High-Risk Breast Clinic

Erica S. Doubleday, MSN, APRN, FNP-C,Peggy Jo Alker, MSN, APRN, FNP-C

Volume 16, Number 1 (Jan/Feb 2025)

17 min read

Breast Cancer Colorectal Cancer Gastrointestinal Cancer Lung Cancer Prostate Cancer Multiple Myeloma Lymphoma Palliative Care CAR T-Cell Therapy Immunotherapy

Stay current on the FDA's new approvals and expanded indications in the oncology field. For select new agents, you'll also find video commentary from a clinical pharmacist expert, sharing their perspective on how the news affects the treatment landscape and what the advanced practitioner needs to know.

Learn More